Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
10 Juni 2021 - 2:00PM
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical
company advancing new treatments for patients suffering from
serious diseases but underserved by today’s therapies, today
announced that Jonathan Violin, Ph.D., President and Chief
Executive Officer of Viridian, will participate in a fireside chat
at the virtual JMP Securities Life Sciences Conference taking place
June 16 – 17, 2021.
Event: |
The JMP Securities Life Sciences Conference |
Date: |
Thursday, June 17 |
Fireside Chat
Time: |
2:30 p.m. ET |
Webcast information for these events will be accessible on the
Events page under the Investors section of the Viridian
Therapeutics website at www.viridiantherapeutics.com. A replay
of the fireside chat will be archived on the website and available
for approximately 90 days following the live event.
About Viridian Therapeutics
Viridian Therapeutics is a biotechnology company advancing new
treatments for patients suffering from serious diseases but
underserved by today’s therapies. Viridian’s most advanced program,
VRDN-001, is an anti-IGF-1R monoclonal antibody in development for
TED, a debilitating auto-immune disease that causes inflammation
and fibrosis within the orbit of the eye which can cause double
vision, pain, and potential blindness. Patients with severe disease
often require multiple remedial surgeries to the orbit, eye
muscles, and eyelids. Viridian is based in Boulder, Colorado, and
Waltham, Massachusetts. Learn more about Viridian and its programs
at https://www.viridiantherapeutics.com/.
Follow us on Twitter @ViridianThera and on LinkedIn.
Viridian
Contacts:Investors:Dan FerryLifeSci
Advisors617-430-7576IR@viridiantherapeutics.com
Media:Darby PearsonVerge Scientific
Communications703-587-0831PR@viridiantherapeutics.com
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024